CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

SUN PHARMACEUTICAL INDUSTRIES INC recalls Fexofenadine Hydrochloride…

SUN PHARMACEUTICAL INDUSTRIES INC recalls Fexofenadine Hydrochloride Tablets

Read the official FDA notice

Published
8 Jul 2026
Units affected
9,048 bottles
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30

Brand / company
SUN PHARMACEUTICAL INDUSTRIES INC
Codes / lots
Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026
Distribution
U.S. Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 8 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.